Aker BioMarine AS engages in the offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products for nutraceutical, pet food, and aquaculture industries in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill oil; QRILL Aqua, an ingredient for formulated feeds; and QRILL Pet, a functional marine ingredient for pets. The company also offers LYSOVETA, a supplement product for brain health; Understory, a protein peptides product; and PL+, a delivery platform for human health sector. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles plastic streams and biological residue. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
Stock data | 2024 | Change |
---|---|---|
Price | $4.94 | N/A |
Employees | 626.00 | N/A |